OPERON

OPERON was founded in 1973 as an R&D laboratory in the field of Immunochemistry. At the beginning, the company’s objective was to satisfy the needs of the Spanish market. The initial products were immunoplates, polyclonal antibodies labeled with peroxidase or fluorescein, and latex agglutination products.

In 1983, OPERON started its export sales operations and in 1986 became the first company in Spain to initiate research and production of monoclonal antibodies. In the 1990s it was again a pioneer in the development, manufacture and sale of immunochromatography tests. After investing in this line of work, in 1992 OPERON launched the product Simple hCG, its first immunochromatography test (a pregnancy test) on the market.

The expression of recombinant proteins began in 2002 and in early 2004 it was also one of the first Spanish companies to develop, manufacture and sell tests based on molecular diagnostic techniques, the product ThromboStrip being the first in this line of molecular diagnostics, based on the genotyping of mutations associated with the risk of venous thrombosis. Since then, its portfolio of products in these lines has been increasing considerably.

OPERON currently has distributors with its own brand name in more than 50 countries, covering three different fields of diagnostics: human clinical, veterinary and food sector, firmly committed to continue offering the highest levels of quality in its main lines of business:

• Raw materials: monoclonal antibodies and recombinant antigens.
• Immunochromatography: rapid lateral flow tests.
• Molecular Diagnostics: molecular diagnostic tests (Opegen and RT-PCR products).
• Customized Services: contract manufacturing of tests and raw materials.